|
⚲
|
| Keyboard |
| Christopher Guiffre | |
|---|---|
| Firm | |
| Address | 55 Chapel Street Suite 102 Newton, MA 02458 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Auron Therapeutics Inc | 021-454017 | Executive Officer | 38.4 M of 48.2 M |
||
| Pear Therapeutics Inc | 021-383679 | Executive Officer | 132.0 M of 132.0 M |
||
| Pear Therapeutics Inc | 021-329643 | Executive Officer | 64.3 M of 65.0 M |
||
| Pear Therapeutics Inc | 021-303091 | Executive Officer | 46.0 M of 51.0 M |
||
| Cerulean Pharma Inc | 021-272672 | Executive Officer | 0.0 M of 0.0 M |
||
| Cerulean Pharma Inc | 021-188408 | Executive Officer | 13.0 M of 13.0 M |
||
| Mercator Therapeutics Inc | 021-146121 | Executive Officer | 2.0 M of 2.0 M |
||
| Related People Network |
|---|
| Network #376 at Cerulean Pharma Inc — files alongside 20 co-filers |